These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1635055)

  • 1. Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands.
    Yu MJ; McCowan JR; Mason NR; Deeter JB; Mendelsohn LG
    J Med Chem; 1992 Jul; 35(14):2534-42. PubMed ID: 1635055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
    Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E
    Farmaco; 1996 May; 51(5):333-9. PubMed ID: 8767843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazolinone cholecystokinin-B receptor ligands.
    Yu MJ; Thrasher KJ; McCowan JR; Mason NR; Mendelsohn LG
    J Med Chem; 1991 Apr; 34(4):1505-8. PubMed ID: 2016728
    [No Abstract]   [Full Text] [Related]  

  • 4. Amide bond replacements incorporated into CCK-B selective "dipeptoids".
    Fincham CI; Higginbottom M; Hill DR; Horwell DC; O'Toole JC; Ratcliffe GS; Rees DC; Roberts E
    J Med Chem; 1992 Apr; 35(8):1472-84. PubMed ID: 1573640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles.
    Perregaard J; Moltzen EK; Meier E; Sánchez C
    J Med Chem; 1995 May; 38(11):1998-2008. PubMed ID: 7783131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
    J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
    Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
    Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists.
    Lattmann E; Billington DC; Poyner DR; Howitt SB; Offel M
    Drug Des Discov; 2001; 17(3):219-30. PubMed ID: 11469752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anti-inflammatory and analgesic activity of some new 4(3H)-quinazolinone derivatives.
    Yeşilada A; Koyunoğlu S; Saygilia N; Kupeli E; Yeşilada E; Bedir E; Khanc I
    Arch Pharm (Weinheim); 2004 Feb; 337(2):96-104. PubMed ID: 14981666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1995 Dec; 294(2-3):511-9. PubMed ID: 8750713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinones.
    Gürsoy A; Karali N
    Eur J Med Chem; 2003 Jun; 38(6):633-43. PubMed ID: 12832136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent.
    Peet NP; Baugh LE; Sunder S; Lewis JE; Matthews EH; Olberding EL; Shah DN
    J Med Chem; 1986 Nov; 29(11):2403-9. PubMed ID: 2431144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
    Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT
    Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Kurczab R; Romeo G
    Bioorg Med Chem; 2017 Feb; 25(3):1250-1259. PubMed ID: 28063784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of thiadiazol derivatives of 4(3H)-quinazolinone as potential antimicrobial agents.
    Khalil MA; Habib NS
    Farmaco Sci; 1987 Dec; 42(12):973-8. PubMed ID: 3449395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation.
    Pirotte B; de Tullio P; Podona T; Diouf O; Dewalque D; Neven P; Masereel B; Caignard P DH; Renard P; Delarge J
    Eur J Pharm Sci; 1998 Dec; 7(1):29-40. PubMed ID: 9845775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new 3-aralkylamino-2-aryl-2H-1, 2,4-pyridothiadiazine 1,1-dioxides as potential CCK-receptor ligands.
    De Tullio P; Pirotte B; Neven P; Masereel B; Dewalque D; Diouf O; Podona T; Caignard D; Renard P; Delarge J
    J Pharm Pharmacol; 1997 May; 49(5):463-71. PubMed ID: 9178178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.